Azitra, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
21 BUSINESS PARK DRIVE, SUITE 6, BRANFORD, CT, 06405
Mailing Address
21 BUSINESS PARK DRIVE, SUITE 6, BRANFORD, CT, 06405
Phone
(203) 489-0183
Fiscal Year End
1231
EIN
464478536
Financial Overview
FY2025 FY
$8K
Revenue
-$8.97M
Net Income
$5.70M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 8-K Current report of material events | March 13, 2026 | View on SEC |
| 8-K Current report of material events | March 5, 2026 | View on SEC |
| 10-K Annual financial report | February 27, 2026 | View on SEC |
| 8-K Current report of material events | February 27, 2026 | View on SEC |
| 8-K Current report of material events | February 6, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
Annual Reports
10-K
February 27, 2026
- Clinical-stage medical dermatology company leveraging unique microbiome technology for skin disease therapies.
- Significantly improved cash position to $15.0 million as of December 31, 2025, due to successful capital raising activities.
Material Events
8-K
Financial Distress
March 13, 2026
High Impact
- NYSE American accepted Azitra's comprehensive plan to regain compliance.
- The company is pursuing strategies like capital raising, cost optimization, and strategic partnerships to improve its financial position.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.